Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ost

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Abdominal Imaging|April 23, 2013
Imaging treated prostate cancerP J L De Visschere, H A Vargas, P Ost, et al.
Acta Clinica Belgica|March 28, 2015
Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaireJ Devos, C Van Praet, K Decaestecker, et al.
European Journal of Cancer Care|November 3, 2017
Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium: Results of a cross-sectional studyR Bultijnck, B Van Ruymbeke, S Everaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2024
Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trialV Fonteyne, C Berghen, C Van Praet, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 3, 2016
Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal RecurrencesP Ost, B A Jereczek-Fossa, N Van As, et al.
European Urology Focus|March 14, 2018
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control StudyT Steuber, C Jilg, P Tennstedt, et al.
European Urology Focus|December 11, 2021
Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II TrialValérie Fonteyne, P Dirix, C Van Praet, et al.
BMC Cancer|May 14, 2020
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trialA De Bruycker, A Spiessens, P Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2025
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upJ Walz, G Attard, A Bjartell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancerP A Sutera, A C Shetty, A Hakansson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Abdominal Imaging|April 23, 2013
Imaging treated prostate cancerP J L De Visschere, H A Vargas, P Ost, et al.
Acta Clinica Belgica|March 28, 2015
Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaireJ Devos, C Van Praet, K Decaestecker, et al.
European Journal of Cancer Care|November 3, 2017
Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium: Results of a cross-sectional studyR Bultijnck, B Van Ruymbeke, S Everaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2024
Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trialV Fonteyne, C Berghen, C Van Praet, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 3, 2016
Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal RecurrencesP Ost, B A Jereczek-Fossa, N Van As, et al.
European Urology Focus|March 14, 2018
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control StudyT Steuber, C Jilg, P Tennstedt, et al.
European Urology Focus|December 11, 2021
Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II TrialValérie Fonteyne, P Dirix, C Van Praet, et al.
BMC Cancer|May 14, 2020
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trialA De Bruycker, A Spiessens, P Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2025
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upJ Walz, G Attard, A Bjartell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancerP A Sutera, A C Shetty, A Hakansson, et al.
Pageof 2